MYL7 Human

Myosin Light Chain 7 Human Recombinant
Cat. No.
BT15819
Source
E.coli.
Synonyms
Myosin light chain 7 regulatory, myosin light polypeptide 7 regulatory, Myosin light chain 2a myosin regulatory light chain 2 atrial isoform, MYL2A, MYLC2A.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

MYL7 Human Recombinant produced in E. coli is a single polypeptide chain containing 199 amino acids (1-175) and having a molecular mass of 22.0kDa.
MYL7 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
MYL7 protein, an atrial isoform of myosin regulatory light chain 2 (MYL2), is a component of myosin, a hexamer composed of four light chains and two heavy chains. Its primary expression is observed in adult atrial muscle.
Description
Recombinantly produced in E. coli, MYL7 Human is a single polypeptide chain consisting of 199 amino acids (residues 1-175) and possesses a molecular mass of 22.0 kDa. The protein is fused to a 24 amino acid His-tag at its N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
A colorless solution that has undergone sterile filtration.
Formulation
The MYL7 solution is provided at a concentration of 0.5 mg/mL and contains 20 mM Tris-HCl buffer (pH 8.0), 100 mM NaCl, 1 mM DTT, and 20% glycerol.
Stability
For optimal storage, maintain the solution at 4°C if the entire vial will be utilized within 2-4 weeks. For extended storage, freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. It is crucial to avoid subjecting the solution to multiple freeze-thaw cycles.
Purity
The purity of the protein is determined to be greater than 90% by SDS-PAGE analysis.
Synonyms
Myosin light chain 7 regulatory, myosin light polypeptide 7 regulatory, Myosin light chain 2a myosin regulatory light chain 2 atrial isoform, MYL2A, MYLC2A.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMASRKA GTRGKVAATK QAQRGSSNVF SMFEQAQIQE FKEAFSCIDQ NRDGIICKAD LRETYSQLGK VSVPEEELDA MLQEGKGPIN FTVFLTLFGE KLNGTDPEEA ILSAFRMFDP SGKGVVNKDE FKQLLLTQAD KFSPAEVEQM FALTPMDLAG NIDYKSLCYI ITHGDEKEE

Product Science Overview

Introduction

Myosin Light Chain 7 (MYL7), also known as Myosin Regulatory Light Chain 7, is a protein coding gene that plays a crucial role in muscle contraction. It is predominantly expressed in adult atrial muscle and is involved in the regulation of cardiac muscle contraction. The human recombinant form of MYL7 is produced using recombinant DNA technology, which allows for the production of large quantities of the protein for research and therapeutic purposes.

Gene and Protein Structure

The MYL7 gene is located on chromosome 12 and encodes a protein that is part of the myosin complex. Myosin is a hexameric protein consisting of two heavy chains and four light chains. The light chains are divided into two types: regulatory light chains and essential light chains. MYL7 belongs to the regulatory light chain category and is involved in modulating the activity of the myosin ATPase, which is essential for muscle contraction .

Function

MYL7 plays a critical role in the regulation of cardiac muscle contraction by modulating the interaction between actin and myosin. It binds to calcium ions, which induces a conformational change in the myosin complex, allowing it to interact with actin filaments and generate force. This process is essential for the proper functioning of the heart and the maintenance of normal cardiac rhythm .

Recombinant Production

The human recombinant form of MYL7 is produced using Escherichia coli (E. coli) expression systems. The gene encoding MYL7 is cloned into a plasmid vector, which is then introduced into E. coli cells. These cells are cultured under specific conditions to induce the expression of the MYL7 protein. The protein is then purified using various chromatographic techniques to obtain a highly pure and biologically active form of MYL7 .

Applications

Recombinant MYL7 is used in various research applications, including studies on cardiac muscle physiology, drug development, and the investigation of cardiac diseases. It is also used in the development of therapeutic interventions for cardiac disorders, as it allows for the detailed study of the molecular mechanisms underlying muscle contraction and the identification of potential drug targets .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.